Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.

It's not clear which children would benefit, when to start the drugs and, once started, whether children would have to stay on them for life You can save this article by registering for free here.

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Donna ...

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

(Gray News) – WeightWatchers is preparing to file for bankruptcy, according to a new report from the Wall Street Journal. The ...